For anesthesia of maxillary incisors, the proper ASA injection site is:

For anesthesia of maxillary incisors, the proper ASA injection site is:

• A. Height of the mucobuccal fold mesial to the root of the canine at the canine fossa
• B. Near the infraorbital nerve
• C. At the apex of the canine
• D. In the palatal mucosa near the incisors

Answer: (A)

Targeting the anterior superior alveolar nerve as it travels in the canine fossa is what provides reliable anesthesia for the maxillary incisors. Depositing the anesthetic at the height of the mucobuccal fold, just mesial to the root of the canine, places the solution near the ASA nerve before it branches to innervate the central and lateral incisors and the canine. This location takes advantage of the nerve’s path in the canine fossa and allows diffusion through the thin bone to reach the nerve with a small-volume injection, giving focused anesthesia to the anterior teeth and associated facial gingiva. Injecting near the infraorbital nerve would numb a broader area and isn’t as precise for the incisors; placing the needle at the apex of the canine is less reliable for consistent ASA blockade; and a palatal mucosa injection targets palatal tissues, not the buccal/labial aspects of the maxillary incisors.

Targeting the anterior superior alveolar nerve as it travels in the canine fossa is what provides reliable anesthesia for the maxillary incisors. Depositing the anesthetic at the height of the mucobuccal fold, just mesial to the root of the canine, places the solution near the ASA nerve before it branches to innervate the central and lateral incisors and the canine. This location takes advantage of the nerve’s path in the canine fossa and allows diffusion through the thin bone to reach the nerve with a small-volume injection, giving focused anesthesia to the anterior teeth and associated facial gingiva. Injecting near the infraorbital nerve would numb a broader area and isn’t as precise for the incisors; placing the needle at the apex of the canine is less reliable for consistent ASA blockade; and a palatal mucosa injection targets palatal tissues, not the buccal/labial aspects of the maxillary incisors.